Founded in 2000, Metabolon is a health technology company that develops platforms and informatics that deliver biomarker discoveries, diagnostic tests, breakthroughs in precision medicine, and partnerships in genomics-based health initiatives. The company specializes in developing clinical diagnostics and prognostic tools for obesity-related chronic diseases and other clinical areas. The company is based in Durham, North Carolina with sales locations in London, United Kingdom; and Madrid, Spain.